| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,494 |
5,095 |
$215K |
| 87428 |
|
3,638 |
2,978 |
$162K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,965 |
2,999 |
$131K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
5,666 |
3,955 |
$69K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
665 |
468 |
$64K |
| 71046 |
Radiologic examination, chest; 2 views |
5,826 |
4,044 |
$59K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
718 |
404 |
$53K |
| 94060 |
|
2,390 |
1,697 |
$46K |
| 93000 |
|
5,797 |
3,952 |
$44K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,964 |
8,291 |
$43K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,028 |
1,321 |
$38K |
| 80305 |
|
9,171 |
7,221 |
$32K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
2,065 |
1,387 |
$23K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
334 |
261 |
$19K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,976 |
800 |
$17K |
| 72100 |
|
1,174 |
833 |
$15K |
| 71250 |
|
574 |
272 |
$14K |
| 93880 |
|
516 |
300 |
$12K |
| 36415 |
Collection of venous blood by venipuncture |
13,775 |
10,236 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,730 |
1,101 |
$11K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
178 |
144 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,437 |
1,129 |
$10K |
| 81003 |
|
8,542 |
6,362 |
$8K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,961 |
1,375 |
$8K |
| 80061 |
Lipid panel |
2,398 |
1,598 |
$7K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
58 |
51 |
$7K |
| 86328 |
|
251 |
99 |
$6K |
| 77080 |
|
389 |
240 |
$6K |
| 74018 |
|
485 |
374 |
$5K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
67 |
41 |
$5K |
| 73562 |
|
290 |
190 |
$4K |
| 76775 |
|
391 |
179 |
$4K |
| 93922 |
|
372 |
194 |
$3K |
| 3008F |
|
5,907 |
3,685 |
$3K |
| 95923 |
|
298 |
181 |
$3K |
| 0011A |
|
127 |
56 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
169 |
138 |
$3K |
| 0031A |
|
100 |
53 |
$3K |
| 99215 |
Prolong outpt/office vis |
75 |
61 |
$3K |
| 0012A |
|
87 |
41 |
$2K |
| 84439 |
|
791 |
525 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
276 |
233 |
$2K |
| 80076 |
|
813 |
573 |
$2K |
| 80053 |
Comprehensive metabolic panel |
1,120 |
734 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
838 |
577 |
$2K |
| 90756 |
|
118 |
89 |
$2K |
| 72040 |
|
112 |
71 |
$1K |
| 93925 |
|
45 |
28 |
$1K |
| 99050 |
|
150 |
94 |
$1K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
422 |
292 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
197 |
142 |
$1K |
| 87210 |
|
447 |
356 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
491 |
339 |
$949.49 |
| 73030 |
|
71 |
53 |
$924.56 |
| 73630 |
|
63 |
51 |
$851.52 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
30 |
16 |
$739.73 |
| 95921 |
|
175 |
110 |
$713.98 |
| 93015 |
|
15 |
12 |
$647.11 |
| 76536 |
|
16 |
13 |
$611.64 |
| 72131 |
|
26 |
16 |
$606.81 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
20 |
14 |
$422.90 |
| 92250 |
|
46 |
28 |
$419.64 |
| 73610 |
|
31 |
26 |
$413.38 |
| 80050 |
General health panel |
41 |
38 |
$386.62 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
271 |
163 |
$347.09 |
| 81025 |
|
62 |
53 |
$320.65 |
| 94690 |
|
13 |
12 |
$301.99 |
| 94760 |
|
277 |
234 |
$251.05 |
| 90674 |
|
36 |
32 |
$226.33 |
| 87275 |
|
45 |
40 |
$208.68 |
| 3079F |
|
56 |
39 |
$140.00 |
| 90686 |
|
29 |
17 |
$131.31 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
137 |
99 |
$126.82 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
15 |
13 |
$117.30 |
| 85651 |
|
97 |
75 |
$116.72 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
514 |
353 |
$106.27 |
| 95117 |
|
17 |
12 |
$94.52 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
561 |
379 |
$73.02 |
| 3074F |
|
36 |
25 |
$70.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
37 |
32 |
$65.24 |
| 81002 |
|
36 |
24 |
$38.50 |
| G0008 |
Administration of influenza virus vaccine |
128 |
116 |
$17.25 |
| 82947 |
|
24 |
12 |
$9.40 |
| 91303 |
|
105 |
53 |
$1.90 |
| 91301 |
|
214 |
97 |
$0.36 |
| 90662 |
|
38 |
30 |
$0.00 |
| 90653 |
|
14 |
13 |
$0.00 |
| G0511 |
Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month |
51 |
41 |
$0.00 |
| 2022F |
|
41 |
27 |
$0.00 |